Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 14/20 | 0.53 |
| ▸ | ATP4B | P51164 | 14/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.53 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | ATP1A1 | P05023 | 7/20 | 0.45 |
| ▸ | ATP1B1 | P05026 | 7/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantoprazole SCHEMBL4763505 | 1.00 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL5795111 | 1.00 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL1560742 | 1.00 | ATP4A (0.53) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL1476428 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL21986309 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL1476069 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL7211409 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL1477291 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL27913225 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 | |
| Pantoprazole SCHEMBL1649650 | 0.99 | ATP4A (0.52) | ATP4AATP4BCYP2C9KDM4ESLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 26501 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036684-A | Preparation method of levorotatory pantoprazole sodium double-hemi-hydrate | 杭州中美华东制药有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260069687-A1 | THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER | ASTELLAS PHARMA INC (JP) | 2026-03-12 | — | — | US | claimed |
| EP-4688866-A1 | BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS | Kisoji Biotechnology Inc. (CA) | 2026-02-11 | — | — | EP | claimed |
| CN-119798220-A | Preparation method of digestive drug intermediate | 山东罗欣药业集团恒欣药业有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025045191-A1 | PANTOPRAZOLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海云晟研新生物科技有限公司 | 2025-03-06 | — | — | WO | claimed |
| CN-119548499-A | Pantoprazole pharmaceutical composition, preparation method and application thereof | 上海云晟研新生物科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| EP-4504786-A1 | ENGINEERED CD200R ANTIBODIES AND USES THEREOF | MiroBio Limited (GB) | 2025-02-12 | — | — | EP | claimed |
| CN-119064364-A | Pantoprazole sodium enteric capsule quality detection device | 湖南明瑞制药股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| WO-2024207112-A1 | BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS | KISOJI BIOTECHNOLOGY INC. (CA) | 2024-10-10 | — | — | WO | claimed |
| US-4331522-A | Reprocessing of spent plasma | EUROPEAN ATOMIC ENERGY COMMISSION (EURATOM) (LU) | 1982-05-25 | — | — | US | claimed |
| US-4304645-A | Process for removing helium and other impurities from a mixture containing deuterium and tritium, and a deuterium/tritium mixture when purified in accordance with such a process | EUROPEAN ATOMIC ENERGY COMMUNITY (EURATOM) (LU) | 1981-12-08 | — | — | US | claimed |
| EP-0032827-A1 | Process for removing helium and other impurities from a mixture containing deuterium and tritium especially from a fusion reactor | EUROPEAN ATOMIC ENERGY COMMUNITY (EURATOM) (LU) | 1981-07-29 | — | — | EP | claimed |
| EP-0016037-A4 | METHOD OF AND APPARATUS FOR PRODUCING A PLASMA CONFIGURATION. | KOLOC PAUL M | 1980-10-09 | — | — | EP | claimed |
| EP-0016037-A1 | METHOD OF AND APPARATUS FOR PRODUCING A PLASMA CONFIGURATION. | KOLOC PAUL M | 1980-10-01 | — | — | EP | claimed |
| EP-0014077-A1 | Continuous process for recycling deuterium/tritium from a fusion reactor for reuse in such a reactor | EUROPEAN ATOMIC ENERGY COMMUNITY (EURATOM) (LU) | 1980-08-06 | — | — | EP | claimed |
| WO-1980000045-A1 | METHOD AND APPARATUS FOR GENERATING AND UTILIZING A COMPOUND PLASMA CONFIGURATION | KOLOC P | 1980-01-10 | — | — | WO | claimed |
| US-4178350-A | Removal of tritium and tritium-containing compounds from a gaseous stream | ENGELHARD MINERALS & CHEMICALS CORP. (US) | 1979-12-11 | — | — | US | claimed |
| US-4075312-A | Process for recovering evolved hydrogen enriched with at least one heavy hydrogen isotope | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1978-02-21 | — | — | US | claimed |
| US-3969631-A | Gas production apparatus | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES ENERGY RESEARCH AND DEVELOPMENT ADMINISTRATION (US) | 1976-07-13 | — | — | US | claimed |